Balanced news tone
News Sentiment
326030 sentiment intelligence
SK Biopharmaceuticals Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-4.4% over one week, -6.3% over four weeks, trend inactive, and near fair-value range.
Price to book forward of SK Biopharmaceuticals Co., Ltd. – KRX:326030
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to book forward of SK Biopharmaceuticals Co., Ltd. – KRX:326030
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:07
- Source
- TradingView
SK Biopharmaceuticals Advances Actinium-Based RPT Cancer Drug Into Clinical Trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- thelec.net
SK Biopharmaceuticals Co., Ltd. | 326030.KS Stock Price & Real-time Quotes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jan 2026 23:12
- Source
- finance.biggo.com